LeMaitre Vascular LMAT ES — Accounts Receivable Net Current
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: LeMaitre Vascular’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 7:01 AM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-073360
The Company closely monitors outstanding receivables for potential collection risks, including those that may arise from economic conditions, in both the United States and international economies. The Company’s European sales to government-owned or supported customers such as hospitals, distributors and agents, particularly in Italy, Spain, and France, may be subject to significant payment delays due to government austerity measures impacting funding and payment practices. As of December 31, 2025, the Company’s receivables in Italy, Spain, and France totaled $1.5 million, $1.2 million and $1.7 million, respectively. Receivables balances with certain government-owned hospitals and government-supported customers in these countries can
Item 16. Form 10-K Summary.
FAQ
- What is LeMaitre Vascular's ES — accounts receivable net current?
- LeMaitre Vascular (LMAT) reported ES — accounts receivable net current of $1.2M in Q4 2025.
- What does ES — accounts receivable net current mean?
- This metric represents the total outstanding balance of invoices owed to the company by customers within the specified geographic segment, net of any allowances for doubtful accounts. It serves as a key indicator of the segment's credit quality and the efficiency of its cash collection processes. Monitoring this balance helps investors assess the liquidity risk and the effectiveness of credit terms offered to regional healthcare providers and distributors.
Ask your AI about LeMaitre Vascular's es — accounts receivable net current.
Connect your AI assistant and compare it to peers, right in your chat.
